Molecular Imaging 2017

Modified RECIST: HCC

Modified RECIST Criteria:

CR

PR

SD

PD

Resolution of arterially enhancing target lesions

At least 30% reduction in sum longest diameter of arterially enhancing target lesions

Response not fulfilling PR or PD category

At least 20% increase in sum

longest diameter of arterially enhancing target lesions or new lesions

Lesions measured in the arterial phase: Max 2 lesions

Hepatocellular Carcinoma

Edeline et al. Cancer 2012;118:147-56